Your browser doesn't support javascript.
loading
RNF43 is frequently mutated in colorectal and endometrial cancers.
Giannakis, Marios; Hodis, Eran; Jasmine Mu, Xinmeng; Yamauchi, Mai; Rosenbluh, Joseph; Cibulskis, Kristian; Saksena, Gordon; Lawrence, Michael S; Qian, Zhi Rong; Nishihara, Reiko; Van Allen, Eliezer M; Hahn, William C; Gabriel, Stacey B; Lander, Eric S; Getz, Gad; Ogino, Shuji; Fuchs, Charles S; Garraway, Levi A.
Afiliação
  • Giannakis M; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. [3] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Hodis E; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. [2] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [3] Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Ma
  • Jasmine Mu X; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. [2] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Yamauchi M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Rosenbluh J; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. [2] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Cibulskis K; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Saksena G; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Lawrence MS; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Qian ZR; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Nishihara R; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. [3] Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA.
  • Van Allen EM; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. [3] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Hahn WC; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. [3] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Gabriel SB; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Lander ES; 1] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. [3] Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, USA.
  • Getz G; 1] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. [2] Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Ogino S; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. [3] Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston,
  • Fuchs CS; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. [2] Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Garraway LA; 1] Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. [3] Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Nat Genet ; 46(12): 1264-6, 2014 Dec.
Article em En | MEDLINE | ID: mdl-25344691
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenocarcinoma / Neoplasias do Endométrio / Proteínas Oncogênicas / Proteínas de Ligação a DNA / Mutação Limite: Female / Humans Idioma: En Revista: Nat Genet Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenocarcinoma / Neoplasias do Endométrio / Proteínas Oncogênicas / Proteínas de Ligação a DNA / Mutação Limite: Female / Humans Idioma: En Revista: Nat Genet Ano de publicação: 2014 Tipo de documento: Article